Using this method, our group previously studied human post-mortem brain samples from Alzheimer’s disease and Parkinson’s disease patients, as well as conditioned media samples from cerebral organoid models,7,35,36 characterizing the Aβ, tau and aSyn aggregates in these samples. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.